The African Union has integrated vetted medical suppliers to ensure rapid access for supplies
The collaboration between Novartis and Africa Medical Supplies Platform (AMSP), a non-profit initiative, aims to help alleviate supply and logistical constraints in the African Union member states.
It comprises the portfolio of 15 generic and over-the-counter (OTC) medicines from Sandoz division which will be sold at zero-profit to governments through Africa Medical Supplies Platform (AMSP) to 55 African and 15 Caricom (Caribbean Community) eligible countries
Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration to facilitate the supply of medicines from the Novartis Pandemic Response Portfolio to the AU member states and Caricom countries.
The AMSP portal is an online marketplace developed under the leadership of the AU Special Envoy, Strive Masiyiwa and powered by Janngo, on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
“Our collaboration with AMSP is a continuation of our efforts at Novartis to combat Covid-19 across the world,” remarked Vas Narasimhan, CEO, Novartis.
“Following the successful listing of test kits, personal protective equipment, and clinical management devices, the African Union Chairperson has expanded our mandate to include groundbreaking medicines to treat pandemic patients in Africa,” said Masiyiwa.
“As a continental body, we are working with several partners to ensure smooth and predictable access to essential medical supplies,” commented Dr John Nkengasong, Director of Africa CDC.
